These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 27836754)

  • 1. Impact of additives on the formation of protein aggregates and viscosity in concentrated protein solutions.
    Bauer KC; Suhm S; Wöll AK; Hubbuch J
    Int J Pharm; 2017 Jan; 516(1-2):82-90. PubMed ID: 27836754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concentration-dependent changes in apparent diffusion coefficients as indicator for colloidal stability of protein solutions.
    Bauer KC; Göbel M; Schwab ML; Schermeyer MT; Hubbuch J
    Int J Pharm; 2016 Sep; 511(1):276-287. PubMed ID: 27421911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Manipulation of lysozyme phase behavior by additives as function of conformational stability.
    Galm L; Morgenstern J; Hubbuch J
    Int J Pharm; 2015 Oct; 494(1):370-80. PubMed ID: 26302861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viscosity-Lowering Effect of Amino Acids and Salts on Highly Concentrated Solutions of Two IgG1 Monoclonal Antibodies.
    Wang S; Zhang N; Hu T; Dai W; Feng X; Zhang X; Qian F
    Mol Pharm; 2015 Dec; 12(12):4478-87. PubMed ID: 26528726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermolecular Interactions and the Viscosity of Highly Concentrated Monoclonal Antibody Solutions.
    Binabaji E; Ma J; Zydney AL
    Pharm Res; 2015 Sep; 32(9):3102-9. PubMed ID: 25832501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein-protein interactions at high concentrations: Effects of ArgHCl and NaCl on the stability, viscosity and aggregation mechanisms of protein solution.
    Ye Y; Huo X; Yin Z
    Int J Pharm; 2021 May; 601():120535. PubMed ID: 33811966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studying Excipient Modulated Physical Stability and Viscosity of Monoclonal Antibody Formulations Using Small-Angle Scattering.
    Xu AY; Castellanos MM; Mattison K; Krueger S; Curtis JE
    Mol Pharm; 2019 Oct; 16(10):4319-4338. PubMed ID: 31487466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific decrease in solution viscosity of antibodies by arginine for therapeutic formulations.
    Inoue N; Takai E; Arakawa T; Shiraki K
    Mol Pharm; 2014 Jun; 11(6):1889-96. PubMed ID: 24689736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Histidine and Sucrose on the Biophysical Properties of a Monoclonal Antibody.
    Baek Y; Singh N; Arunkumar A; Zydney AL
    Pharm Res; 2017 Mar; 34(3):629-639. PubMed ID: 28035628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Arginine and lysine reduce the high viscosity of serum albumin solutions for pharmaceutical injection.
    Inoue N; Takai E; Arakawa T; Shiraki K
    J Biosci Bioeng; 2014 May; 117(5):539-43. PubMed ID: 24268865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bulky Polar Additives That Greatly Reduce the Viscosity of Concentrated Solutions of Therapeutic Monoclonal Antibodies.
    Larson AM; Weight AK; Love K; Bonificio A; Wescott CR; Klibanov AM
    J Pharm Sci; 2017 May; 106(5):1211-1217. PubMed ID: 28137697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimization of high-concentration endostatin formulation: Harmonization of excipients' contributions on colloidal and conformational stabilities.
    Wang S; Zhang X; Wu G; Tian Z; Qian F
    Int J Pharm; 2017 Sep; 530(1-2):173-186. PubMed ID: 28755991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of PEG molecular weight and PEGylation degree on the physical stability of PEGylated lysozyme.
    Morgenstern J; Baumann P; Brunner C; Hubbuch J
    Int J Pharm; 2017 Mar; 519(1-2):408-417. PubMed ID: 28130198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improving Viscosity and Stability of a Highly Concentrated Monoclonal Antibody Solution with Concentrated Proline.
    Hung JJ; Dear BJ; Dinin AK; Borwankar AU; Mehta SK; Truskett TT; Johnston KP
    Pharm Res; 2018 Apr; 35(7):133. PubMed ID: 29713822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Droplet-Based Microfluidic Tool to Quantify Viscosity of Concentrating Protein Solutions.
    Yang D; Daviran M; Schultz KM; Walker LM
    Pharm Res; 2021 Oct; 38(10):1765-1775. PubMed ID: 34664208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viscosity Control of Protein Solution by Small Solutes: A Review.
    Hong T; Iwashita K; Shiraki K
    Curr Protein Pept Sci; 2018; 19(8):746-758. PubMed ID: 29237380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elucidating the weak protein-protein interaction mechanisms behind the liquid-liquid phase separation of a mAb solution by different types of additives.
    Wu G; Wang S; Tian Z; Zhang N; Sheng H; Dai W; Qian F
    Eur J Pharm Biopharm; 2017 Nov; 120():1-8. PubMed ID: 28754261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of colloidal stability of high concentration protein formulations.
    Garidel P; Blume A; Wagner M
    Pharm Dev Technol; 2015 May; 20(3):367-74. PubMed ID: 24392929
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conformational analysis of protein secondary structure during spray-drying of antibody/mannitol formulations.
    Schüle S; Friess W; Bechtold-Peters K; Garidel P
    Eur J Pharm Biopharm; 2007 Jan; 65(1):1-9. PubMed ID: 17034996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stability of buffer-free freeze-dried formulations: A feasibility study of a monoclonal antibody at high protein concentrations.
    Garidel P; Pevestorf B; Bahrenburg S
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):125-39. PubMed ID: 26455339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.